Outset Medical Inc. Insider Trading

Last 12 months

Insiders sold 369K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Financial Officer Renee Gaeta sold 87K on Jun 3, 13% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2022.

Net open-market

−369K

0 buys · 20 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 5

executives and directors

Last open-market buy

Nov 2022

Nov 22, 2022

Get an email when OM's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 1 – 2	Braden Michael Leonard Large holder	Bought 2 parts	244,909	$3.55 average	870K	9.7%	Form 4
Aug 17	Leslie Trigg Chair and CEO	SoldNo plan	3,437	$4.39	15K	1.4%	Form 4
Aug 17	John L. Brottem General Counsel	SoldNo plan	2,632	$4.39	12K	2.9%	Form 4
Aug 17	Renee Gaeta Chief Financial Officer	SoldNo plan	4,543	$4.39	20K	2.5%	Form 4
Jun 3	Renee Gaeta Chief Financial Officer	SoldNo plan	17,672	$4.94	87K	13%	Form 4
May 15	Leslie Trigg Chair and CEO	SoldNo plan	3,445	$3.70	13K	2.4%	Form 4
May 15	Marc Nash EVP Operations R&D & Service	SoldNo plan	1,582	$3.70	6K	4.0%	Form 4
May 15	John L. Brottem General Counsel	SoldNo plan	2,638	$3.70	10K	8.0%	Form 4
Feb 17	Marc Nash EVP Operations R&D & Service	SoldNo plan	1,817	$3.35	6K	4.3%	Form 4
Feb 17	John L. Brottem General Counsel	SoldNo plan	2,842	$3.35	10K	7.9%	Form 4
Feb 17	Leslie Trigg Chair and CEO	SoldNo plan	3,361	$3.35	11K	2.3%	Form 4
Jan 20 – 21	Marc Nash EVP Operations R&D & Service	SoldNo plan 2 parts	6,355	$5.10 average	32K	13%	Form 4
Jan 20 – 21	John L. Brottem General Counsel	SoldNo plan 2 parts	10,494	$5.11 average	54K	23%	Form 4
Jan 20 – 21	Leslie Trigg Chair and CEO	SoldNo plan 2 parts	13,914	$5.11 average	71K	8.6%	Form 4
Jan 7	Marc Nash EVP Operations R&D & Service	SoldNo plan	108	$4.27	$461	0.2%	Form 4
Jan 7	John L. Brottem General Counsel	SoldNo plan	224	$4.27	$956	0.5%	Form 4
Jan 7	Leslie Trigg Chair and CEO	SoldNo plan	1,795	$4.27	8K	1.1%	Form 4
Dec 1, 2025	Karen Drexler Director	SoldNo plan	1,548	$4.37	7K	11%	Form 4
Nov 17, 2025	Leslie Trigg Chair and CEO	SoldNo plan	916	$4.60	4K	0.6%	Form 4
Nov 17, 2025	Marc Nash EVP Operations R&D & Service	SoldNo plan	247	$4.60	1K	0.5%	Form 4
Nov 17, 2025	John L. Brottem General Counsel	SoldNo plan	388	$4.60	2K	0.8%	Form 4
Aug 15, 2025	Leslie Trigg Chair and CEO	SoldNo plan	904	$12.88	12K	0.5%	Form 4
Aug 15, 2025	Marc Nash SVP Operations and R&D	SoldNo plan	243	$12.88	3K	0.6%	Form 4
Aug 15, 2025	John L. Brottem General Counsel	SoldNo plan	383	$12.88	5K	0.8%	Form 4
May 15, 2025	Leslie Trigg Chair and CEO	SoldNo plan	935	$17.80	17K	0.9%	Form 4
May 15, 2025	Marc Nash SVP Operations and R&D	SoldNo plan	252	$17.82	4K	1.8%	Form 4
May 15, 2025	John L. Brottem General Counsel	SoldNo plan	396	$17.82	7K	3.4%	Form 4
May 15, 2025	Nabeel Ahmed Chief Financial Officer	SoldNo plan	584	$17.81	10K	3.5%	Form 4
Feb 18, 2025	Leslie Trigg Chair and CEO	SoldNo plan	14,611	$0.90	13K	1.6%	Form 4
Feb 18, 2025	Marc Nash SVP Operations and R&D	SoldNo plan	4,204	$0.90	4K	2.1%	Form 4
Feb 18, 2025	John L. Brottem General Counsel	SoldNo plan	6,145	$0.90	6K	3.4%	Form 4
Feb 18, 2025	Nabeel Ahmed Chief Financial Officer	SoldNo plan	8,659	$0.90	8K	3.3%	Form 4
Jan 21, 2025	Leslie Trigg Chair and CEO	SoldNo plan 3 parts	65,236	$0.80 average	52K	6.7%	Form 4
Jan 21, 2025	Marc Nash SVP Operations and R&D	SoldNo plan 4 parts	23,221	$0.80 average	19K	10%	Form 4
Jan 21, 2025	John L. Brottem General Counsel	SoldNo plan 3 parts	32,930	$0.80 average	26K	15%	Form 4
Jan 21, 2025	Nabeel Ahmed Chief Financial Officer	SoldNo plan 3 parts	34,288	$0.80 average	27K	12%	Form 4
Jan 13, 2025	Leslie Trigg Chair and CEO	SoldNo plan	33,227	$0.81	27K	3.7%	Form 4
Jan 13, 2025	Marc Nash SVP Operations and R&D	SoldNo plan	15,011	$0.81	12K	6.3%	Form 4
Jan 13, 2025	John L. Brottem General Counsel	SoldNo plan	20,492	$0.81	17K	9.1%	Form 4
Jan 13, 2025	Nabeel Ahmed Chief Financial Officer	SoldNo plan	29,031	$0.81	24K	9.4%	Form 4

Oct 1 – 2
Braden Michael Leonard
Large holder · bought 244,909 at avg $3.55
870K
9.7% of stake
Aug 17No plan
Leslie Trigg
Chair and CEO · sold 3,437 at $4.39
15K
1.4% of stake
Aug 17No plan
John L. Brottem
General Counsel · sold 2,632 at $4.39
12K
2.9% of stake
Aug 17No plan
Renee Gaeta
Chief Financial Officer · sold 4,543 at $4.39
20K
2.5% of stake
Jun 3No plan
Renee Gaeta
Chief Financial Officer · sold 17,672 at $4.94
87K
13% of stake
May 15No plan
Leslie Trigg
Chair and CEO · sold 3,445 at $3.70
13K
2.4% of stake
May 15No plan
Marc Nash
EVP Operations R&D & Service · sold 1,582 at $3.70
6K
4.0% of stake
May 15No plan
John L. Brottem
General Counsel · sold 2,638 at $3.70
10K
8.0% of stake
Feb 17No plan
Marc Nash
EVP Operations R&D & Service · sold 1,817 at $3.35
6K
4.3% of stake
Feb 17No plan
John L. Brottem
General Counsel · sold 2,842 at $3.35
10K
7.9% of stake
Feb 17No plan
Leslie Trigg
Chair and CEO · sold 3,361 at $3.35
11K
2.3% of stake
Jan 20 – 21No plan
Marc Nash
EVP Operations R&D & Service · sold 6,355 at avg $5.10
32K
13% of stake
Jan 20 – 21No plan
John L. Brottem
General Counsel · sold 10,494 at avg $5.11
54K
23% of stake
Jan 20 – 21No plan
Leslie Trigg
Chair and CEO · sold 13,914 at avg $5.11
71K
8.6% of stake
Jan 7No plan
Marc Nash
EVP Operations R&D & Service · sold 108 at $4.27
$461
0.2% of stake
Jan 7No plan
John L. Brottem
General Counsel · sold 224 at $4.27
$956
0.5% of stake
Jan 7No plan
Leslie Trigg
Chair and CEO · sold 1,795 at $4.27
8K
1.1% of stake
Dec 1, 2025No plan
Karen Drexler
Director · sold 1,548 at $4.37
7K
11% of stake
Nov 17, 2025No plan
Leslie Trigg
Chair and CEO · sold 916 at $4.60
4K
0.6% of stake
Nov 17, 2025No plan
Marc Nash
EVP Operations R&D & Service · sold 247 at $4.60
1K
0.5% of stake
Nov 17, 2025No plan
John L. Brottem
General Counsel · sold 388 at $4.60
2K
0.8% of stake
Aug 15, 2025No plan
Leslie Trigg
Chair and CEO · sold 904 at $12.88
12K
0.5% of stake
Aug 15, 2025No plan
Marc Nash
SVP Operations and R&D · sold 243 at $12.88
3K
0.6% of stake
Aug 15, 2025No plan
John L. Brottem
General Counsel · sold 383 at $12.88
5K
0.8% of stake
May 15, 2025No plan
Leslie Trigg
Chair and CEO · sold 935 at $17.80
17K
0.9% of stake
May 15, 2025No plan
Marc Nash
SVP Operations and R&D · sold 252 at $17.82
4K
1.8% of stake
May 15, 2025No plan
John L. Brottem
General Counsel · sold 396 at $17.82
7K
3.4% of stake
May 15, 2025No plan
Nabeel Ahmed
Chief Financial Officer · sold 584 at $17.81
10K
3.5% of stake
Feb 18, 2025No plan
Leslie Trigg
Chair and CEO · sold 14,611 at $0.90
13K
1.6% of stake
Feb 18, 2025No plan
Marc Nash
SVP Operations and R&D · sold 4,204 at $0.90
4K
2.1% of stake
Feb 18, 2025No plan
John L. Brottem
General Counsel · sold 6,145 at $0.90
6K
3.4% of stake
Feb 18, 2025No plan
Nabeel Ahmed
Chief Financial Officer · sold 8,659 at $0.90
8K
3.3% of stake
Jan 21, 2025No plan
Leslie Trigg
Chair and CEO · sold 65,236 at avg $0.80
52K
6.7% of stake
Jan 21, 2025No plan
Marc Nash
SVP Operations and R&D · sold 23,221 at avg $0.80
19K
10% of stake
Jan 21, 2025No plan
John L. Brottem
General Counsel · sold 32,930 at avg $0.80
26K
15% of stake
Jan 21, 2025No plan
Nabeel Ahmed
Chief Financial Officer · sold 34,288 at avg $0.80
27K
12% of stake
Jan 13, 2025No plan
Leslie Trigg
Chair and CEO · sold 33,227 at $0.81
27K
3.7% of stake
Jan 13, 2025No plan
Marc Nash
SVP Operations and R&D · sold 15,011 at $0.81
12K
6.3% of stake
Jan 13, 2025No plan
John L. Brottem
General Counsel · sold 20,492 at $0.81
17K
9.1% of stake
Jan 13, 2025No plan
Nabeel Ahmed
Chief Financial Officer · sold 29,031 at $0.81
24K
9.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OM, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with OM

CompareIntrinsic value

ZYXIQZynex Inc

No recent price20

BLFSBiolife Solutions Inc.

No recent price61

FONRFonar Corp

No recent price53

CBLLCeribell, Inc.

$27.39-3.11%25

VASOVaso Corporation

$0.29+0.00%37

ELMDElectromed Inc.

$28.01+4.83%75

EDAPEdap Tms SA

$4.34+5.60%15

IRIXIridex Corporation

$0.72+2.86%25

Held by ETFs

OM is in 2 US ETFs. The largest of them, with OM's weight in each:

Spot a number that looks wrong? Check it in OM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OM

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.